Miconazole-loaded nanoparticles coated with hyaluronic acid to treat vulvovaginal candidiasis.
暂无分享,去创建一个
Renata Tupinambá Branquinho | A. Quaresma | Ana Paula Moreira Barboza | Marcelo G F Araújo | J. T. Magalhães | M. B. Marques | Stephanie Lourrani Evangelista Neves Santos | S. A. Moura | Gisele Rodrigues Da Silva | Aniely Dos Reis Teixeira | Fábio Henrique Rodrigues Da Silva
[1] H. Liang,et al. Vaginal Epithelial Cell Membrane-Based Phototherapeutic Decoy Confers a "Three-in-One" Strategy to Treat against Intravaginal Infection of Candida albicans. , 2023, ACS nano.
[2] L. Cerofolini,et al. Functionalized Hyaluronic Acid for “In Situ” Matrix Metalloproteinase Inhibition: A Bioactive Material to Treat the Dry Eye Sydrome , 2022, ACS macro letters.
[3] A. Silva-Cunha,et al. Sodium butyrate-loaded nanoparticles coated with chitosan for the treatment of neovascularization in age-related macular degeneration: ocular biocompatibility and antiangiogenic activity. , 2022, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[4] M. Moniruzzaman,et al. Ionic Liquid and Tween-80 Mixture as an Effective Dispersant for Oil Spills: Toxicity, Biodegradability, and Optimization , 2022, ACS omega.
[5] D. Helal,et al. Polymeric versus lipid nanocapsules for miconazole nitrate enhanced topical delivery: in vitro and ex vivo evaluation , 2022, Drug delivery.
[6] S. H. Alves,et al. Mucoadhesive gellan gum hydrogel containing diphenyl diselenide-loaded nanocapsules presents improved anti-candida action in a mouse model of vulvovaginal candidiasis. , 2021, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[7] L. Cantu',et al. Structure and Fate of Nanoparticles Designed for the Nasal Delivery of Poorly Soluble Drugs. , 2021, Molecular pharmaceutics.
[8] B. Billack,et al. Evaluation of the antifungal activity of an Ebselen-loaded Nanoemulsion in a mouse model of vulvovaginal candidiasis. , 2021, Nanomedicine : nanotechnology, biology, and medicine.
[9] D. Monteiro,et al. Nanocarriers of Miconazole or Fluconazole: Effects on Three-Species Candida Biofilms and Cytotoxic Effects In Vitro , 2021, Journal of fungi.
[10] B. Sarmento,et al. Clotrimazole-loaded N-(2-hydroxy)-propyl-3-trimethylammonium, O-palmitoyl chitosan nanoparticles for topical treatment of vulvovaginal candidiasis. , 2021, Acta biomaterialia.
[11] M. Bruschi,et al. Preclinical approaches in vulvovaginal candidiasis treatment with mucoadhesive thermoresponsive systems containing propolis , 2020, PloS one.
[12] A. Klibanov,et al. Vancomycin-loaded N,N-dodecyl,methyl-polyethylenimine nanoparticles coated with hyaluronic acid to treat bacterial endophthalmitis: Development, characterization, and ocular biocompatibility. , 2020, International journal of biological macromolecules.
[13] V. Lassalle,et al. Nanoparticulated Systems Based on Natural Polymers Loaded with Miconazole Nitrate and Lidocaine for the Treatment of Topical Candidiasis , 2020, AAPS PharmSciTech.
[14] Tamer M Samir,et al. Formulation and Characterization of Sertaconazole Nitrate Mucoadhesive Liposomes for Vaginal Candidiasis , 2020, International journal of nanomedicine.
[15] G. R. da Silva,et al. Amphotericin B-loaded Eudragit RL100 nanoparticles coated with hyaluronic acid for the treatment of vulvovaginal candidiasis. , 2020, Carbohydrate polymers.
[16] P. Nyirjesy,et al. Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes , 2019, BMC Women's Health.
[17] Peng Zhang,et al. A potential carrier for anti-tumor targeted delivery-hyaluronic acid nanoparticles. , 2019, Carbohydrate polymers.
[18] G. Fabbrocini,et al. Biofilms and vulvovaginal candidiasis. , 2019, Colloids and surfaces. B, Biointerfaces.
[19] A. Tedesco,et al. Miconazole loaded chitosan-based nanoparticles for local treatment of vulvovaginal candidiasis fungal infections. , 2019, Colloids and surfaces. B, Biointerfaces.
[20] R. Oréfice,et al. Biodegradable core-shell electrospun nanofibers containing bevacizumab to treat age-related macular degeneration , 2018, Journal of Materials Science: Materials in Medicine.
[21] J. Sobel,et al. Global burden of recurrent vulvovaginal candidiasis: a systematic review. , 2018, The Lancet. Infectious diseases.
[22] Z. Hussain,et al. Hyaluronic acid decorated tacrolimus-loaded nanoparticles: Efficient approach to maximize dermal targeting and anti-dermatitis efficacy. , 2018, Carbohydrate polymers.
[23] R. Oréfice,et al. Amphotericin B-Loaded Poly(lactic-co-glycolic acid) Nanofibers: An Alternative Therapy Scheme for Local Treatment of Vulvovaginal Candidiasis. , 2018, Journal of pharmaceutical sciences.
[24] M. Arpi,et al. [Diagnosis of vaginal discharge]. , 2018, Ugeskrift for laeger.
[25] Guilherme M Gelfuso,et al. Novel ex vivo protocol using porcine vagina to assess drug permeation from mucoadhesive and colloidal pharmaceutical systems. , 2017, Colloids and surfaces. B, Biointerfaces.
[26] Abhijeet Pandey,et al. Aripiprazole loaded poly(caprolactone) nanoparticles: Optimization and in vivo pharmacokinetics. , 2016, Materials science & engineering. C, Materials for biological applications.
[27] Dongmei Li,et al. Combination of Estrogen and Immunosuppressive Agents to Establish a Mouse Model of Candidiasis with Concurrent Oral and Vaginal Mucosal Infection , 2016, Mycopathologia.
[28] V. Pillay,et al. A Novel Melt-Dispersion Technique for Simplistic Preparation of Chlorpromazine-Loaded Polycaprolactone Nanocapsules , 2015 .
[29] W. Mendling. Guideline: Vulvovaginal Candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis) , 2015, Mycoses.
[30] R. Cone,et al. Vaginal pH and Microbicidal Lactic Acid When Lactobacilli Dominate the Microbiota , 2013, PloS one.
[31] C. Sotomayor,et al. Evaluation of Syngonanthus nitens (Bong.) Ruhl. extract as antifungal and in treatment of vulvovaginal candidiasis. , 2013, Medical mycology.
[32] P. Adriaensens,et al. Solid state solubility of miconazole in poly[(ethylene glycol)-g-vinyl alcohol] using hot-melt extrusion. , 2012, Molecular pharmaceutics.
[33] D. Nečas,et al. Gwyddion: an open-source software for SPM data analysis , 2012 .
[34] M. Grossmann,et al. The effect of surfactant Tween 80 on the hydrophilicity, water vapor permeation, and the mechanical properties of cassava starch and poly(butylene adipate-co-terephthalate) (PBAT) blend films. , 2010 .
[35] Frederic Lagarce,et al. Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery. , 2010, Nanomedicine.
[36] J. Sobel,et al. Vulvovaginal candidosis , 2007, The Lancet.
[37] J. Sobel,et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. , 2004, The New England journal of medicine.
[38] C. Steele,et al. Effects of Reproductive Hormones on Experimental Vaginal Candidiasis , 2000, Infection and Immunity.
[39] J. Sobel,et al. Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity , 1995, Infection and immunity.
[40] Hatem Fessi,et al. Nanocapsule formation by interfacial polymer deposition following solvent displacement , 1989 .
[41] J. Sobel. Management of recurrent vulvovaginal candidiasis with intermittent ketoconazole prophylaxis. , 1985, Obstetrics and gynecology.
[42] Maristela Pereira,et al. Development, characterization, and in vitro‐in vivo evaluation of polymeric nanoparticles containing miconazole and farnesol for treatment of vulvovaginal candidiasis , 2019, Medical mycology.
[43] J. Sobel. Recurrent vulvovaginal candidiasis. , 1987, American journal of obstetrics and gynecology.